Citigroup Inc Stereotaxis, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Citigroup Inc holds 3,119 shares of STXS stock, worth $6,892. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,119

Previous 21,025 85.17%

Holding current value

$6,892

Previous $44,000 79.55%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$2.14 - $3.06 $38,318 - $54,792	-17,906 Reduced 85.17%	3,119 $9,000
Q2 2025 Aug 11, 2025	SELL	$1.6 - $2.37 $31,364 - $46,459	-19,603 Reduced 48.25%	21,025 $44,000
Q1 2025 May 12, 2025	SELL	$1.76 - $2.64 $8,303 - $12,455	-4,718 Reduced 10.4%	40,628 $71,000
Q4 2024 Feb 12, 2025	BUY	$1.84 - $2.47 $10,624 - $14,261	5,774 Added 14.59%	45,346 $103,000
Q3 2024 Nov 12, 2024	BUY	$1.76 - $2.35 $48,605 - $64,899	27,617 Added 231.01%	39,572 $80,000

Q2 2024 Aug 12, 2024	SELL	$1.73 - $3.2 $416,994 - $771,318	-241,037 Reduced 95.27%	11,955 $21,000
Q1 2024 May 10, 2024	BUY	$1.74 - $3.16 $102,945 - $186,958	59,164 Added 30.52%	252,992 $660,000
Q4 2023 Feb 09, 2024	BUY	$1.42 - $1.96 $262,266 - $362,002	184,695 Added 2022.28%	193,828 $339,000
Q3 2023 Nov 09, 2023	BUY	$1.42 - $1.84 $12,968 - $16,804	9,133 New	9,133 $14,000
Q4 2022 Feb 09, 2023	BUY	$1.55 - $2.38 $15,166 - $23,288	9,785 New	9,785 $20,000
Q2 2022 Aug 10, 2022	SELL	$1.75 - $3.71 $8,510 - $18,041	-4,863 Reduced 90.54%	508 $1,000
Q1 2022 May 12, 2022	SELL	$3.11 - $6.63 $38,324 - $81,701	-12,323 Reduced 69.65%	5,371 $20,000
Q4 2021 Feb 10, 2022	BUY	$5.14 - $6.84 $1,028 - $1,368	200 Added 1.14%	17,694 $110,000
Q3 2021 Nov 10, 2021	BUY	$5.34 - $9.87 $93,417 - $172,665	17,494 New	17,494 $94,000

Others Institutions Holding STXS

# of Institutions

112

Shares Held

43M

Call Options Held

13.8K

Put Options Held

31.4K

View Full List

About Stereotaxis, Inc.

Ticker STXS
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,790,096
Market Cap $165M
Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...

More about STXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account